title: Secukinumab versus ustekinumab: "CLEAR" conclusions are needed.
authors.affiliation: Department of Dermatology, Veterans Administration Hospital (NIMTS), Athens, Greece. Electronic address: efrall@otenet.gr.
authors.forename: Efstathios Andreas
authors.initials: EA
authors.lastname: Rallis
authors.affiliation: Department of Dermatology, Veterans Administration Hospital (NIMTS), Athens, Greece.
authors.forename: Constantinos
authors.initials: C
authors.lastname: Christodoulopoulos
authors.affiliation: Department of Dermatology, Veterans Administration Hospital (NIMTS), Athens, Greece.
authors.forename: Constantinos
authors.initials: C
authors.lastname: Verros
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D004311:Double-Blind Method; D006801:Humans; D011565:Psoriasis; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069549:Ustekinumab